Commentary
The presence or recurrence of metabolic syndrome following liver transplantation can contribute to the development and recurrence of NAFLD in the liver allograft.
In this review, Z. Spiritos and M. F. Abdelmalek discuss the endogenous and exogenous drivers of post-transplant metabolic syndrome, role of chronic immunosuppression, and the prevalence and clinical significant of post-transplant metabolic syndrome on nonalcoholic steatohepatitis.
